4.7 Article

Estimation of Hepatic Proton-Density Fat Fraction by Using MR Imaging at 3.0 T

Journal

RADIOLOGY
Volume 258, Issue 3, Pages 749-759

Publisher

RADIOLOGICAL SOC NORTH AMERICA
DOI: 10.1148/radiol.10100659

Keywords

-

Funding

  1. Bayer Healthcare [070525]
  2. National Institutes of Health [R01 DK075128]
  3. RSNA
  4. ISMRM
  5. GE
  6. UCSD Tech Transfer
  7. Merck
  8. VirtualScopics
  9. Intuitive Surgical
  10. Allergan Medical
  11. Olympus
  12. USGI Medical
  13. GORE Medical
  14. Valentx
  15. Allergan
  16. USGI
  17. Medigus
  18. Bayer
  19. ISIS
  20. Bracco
  21. Medscape
  22. ICPME

Ask authors/readers for more resources

Purpose: To compare the accuracy of several magnetic resonance (MR) imaging-based methods for hepatic proton-density fat fraction (FF) estimation at 3.0 T, with spectroscopy as the reference technique. Materials and Methods: This prospective study was institutional review board approved and HIPAA compliant. Informed consent was obtained. One hundred sixty-three subjects (39 with known hepatic steatosis, 110 with steatosis risk factors, 14 without risk factors) underwent proton MR spectroscopy and non-T1-weighted gradient-echo MR imaging of the liver. At spectroscopy, the reference FF was determined from frequency-selective measurements of fat and water proton densities. At imaging, FF was calculated by using two-, three-, or six-echo methods, with single-frequency and multifrequency fat signal modeling. The three-and six-echo methods corrected for T2*; the two-echo methods did not. For each imaging method, the fat estimation accuracy was assessed by using linear regression between the imaging FF and spectroscopic FF. Binary classification accuracy of imaging was assessed at four reference spectroscopic thresholds (0.04, 0.06, 0.08, and 0.10 FF). Results: Regression intercept of two-, three-, and six-echo methods were -0.0211, 0.0087, and -0.0062 (P<.001 for all three) without multifrequency modeling and -0.0237 (P<.001), 0.0022, and -0.0007 with multifrequency modeling, respectively. Regression slope of two-, three-, and six-echo methods were 0.8522, 0.8528, and 0.7544 (P<.001 for all three) without multifrequency modeling and 0.9994, 0.9775, and 0.9821 with multifrequency modeling, respectively. Significant deviation of intercept and slope from 0 and 1, respectively, indicated systematic error. Classification accuracy was 82.2%-90.1%, 93.9%-96.3%, and 83.4%-89.6% for two-, three-, and six-echo methods without multifrequency modeling and 88.3%-92.0%, 95.1%-96.3%, and 94.5%-96.3% with multifrequency modeling, respectively, depending on the FF threshold. T2* -corrected (three-and six-echo) multifrequency imaging methods had the overall highest FF estimation and classification accuracy. Among methods without multifrequency modeling, the T2* -corrected three-echo method had the highest accuracy. Conclusion: Non-T1-weighted MR imaging with T2* correction and multifrequency modeling helps accurately estimate hepatic proton-density FF at 3.0 T. (C)RSNA, 2011

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available